Zydus, Guardant Health to promote Guardant360 genomic tests for cancers in India and Nepal
The agreement demonstrates a shared commitment to advance precision medicine and improve patient outcomes in the region
The agreement demonstrates a shared commitment to advance precision medicine and improve patient outcomes in the region
The inspection of the facility conducted from August 7 to August 11, 2023
India is following a holistic and inclusive approach in alignment with the vison of Universal Health Coverage and the resolute commitment to ‘leave no one behind
2023 Nobel laureates discovered how pseudouridine could make mRNA suitable for vaccines
The companies plan to start a pivotal Phase 3 trial in the coming months
RHTC will address a long-standing healthcare access issue for all the local population
The sBLA is supported by a usability study which confirmed that individuals over 18 years of age could self-administer
The Responsible Export Organisation (REO) certification is a distinguished recognition awarded by the Confederation of Indian Industry (CII)
The company expects that this development could improve the strength of its application to the FDA for new drug approval
Orgovyx is the first and only oral GnRH receptor antagonist approved for advanced prostate cancer in Canada
Subscribe To Our Newsletter & Stay Updated